Full-Time

Senior Systems Engineer

Cloud Solutions, Hybrid

Confirmed live in the last 24 hours

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Develops insulin delivery systems for diabetes

Compensation Overview

$99.8k - $149.7k/yr

Senior

Acton, MA, USA + 1 more

More locations: San Diego, CA, USA

Hybrid

Requires on-site work from an Insulet office at least three (3) days per week.

Category
DevOps & Infrastructure
Cloud Engineering
Required Skills
Microservices
REST APIs
Requirements
  • Bachelor of Science or equivalent degree in Software Engineering, Computer Science or related field
  • 5+ years of overall experience in software industry in engineering or related roles
  • 5+ years of experience working as a Systems engineer in cloud-based products
  • 3+ years hands on experience in building performance models, developing non-functional requirements and supporting system integrations including grey box testing
  • Understanding of web services, microservices, HTTP protocols, REST APIs, SOA
  • Database concepts and usage
  • Work with large cross-functional teams
  • Data models, data driven requirements and data governance
  • Systems engineering practices such as system architecture, requirements management, design trade-off and cost-benefit analysis, hazards and risk assessments
  • Concept generation, developing performance models and non-functional requirements
  • Project team skills: experience and capability working collaboratively under a Quality Management System (QMS), as part of a cross-functional team that includes development, verification/validation, marketing, clinical, regulatory and quality experts.
Responsibilities
  • Serve as a key member of a cross-functional project team consisting of software, analytics, Site reliability engineers, Cloud Operations, Medical, Marketing, Data engineering, Privacy, Regulatory, Product owners, Product Managers and quality engineers to achieve project deliverables
  • Lead system definition tasks such as generating user needs, product requirements, and use-case descriptions
  • Contribute to system development by defining solution architecture and concept generation
  • Own the System Hazard Analysis and conducts safety risk assessment of issues
  • Provide system impact and safety risk assessment of component failure modes as input to DFMEA
  • Triage and/or troubleshoot production issues and incorporate into requirements and risk documents
  • Develop performance models and non-functional requirements in support of system scalability and performance
  • Serve as technical consulting resource for integration, subsystem and system verification activities creating integration plans, perform review of test coverage and hands on integration testing
  • Create and maintain traceability among design input, design output, verification and validation, and risk management artifacts to ensure completeness and fully traceable design history file
  • Participate in review of data models and generate data mapping, data driven requirements as needed.
Desired Qualifications
  • Master of Science degree is a plus
  • System Engineering training and/or certification is a plus
  • Experience or formal training in established Systems Engineering concepts
  • Prior experience integrating/testing cloud connected mobile applications on Android/iOS platforms a plus
  • Experience reviewing verification plans, protocols and reports in a regulated industry.
  • Familiarity with IEC 62304, ISO 14971, FDA regulations and international standards applicable to medical device software development, verification, and validation a plus

Insulet Corporation develops and manufactures insulin delivery systems specifically for individuals with diabetes. Its main product, the Omnipod, is a tubeless and waterproof insulin pump that allows for continuous insulin infusion under the skin. This system is designed to be more convenient and discreet compared to traditional insulin pumps that use tubing, making diabetes management easier for users. Insulet operates globally, with its headquarters in Acton, Massachusetts, and has manufacturing facilities in various countries. The company focuses on selling the Omnipod system, which includes disposable pods and a personal diabetes manager (PDM). Insulet targets people with insulin-dependent diabetes who prefer a flexible and user-friendly method of insulin delivery. The company is also advancing its product line with newer versions like the Omnipod 5, which features automated insulin delivery that works with continuous glucose monitors.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Acton, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Omnipod 5 iPhone app launch enhances user experience with Dexcom G7 compatibility.
  • Insulet's humorous campaign and Marvel collaboration boost brand visibility and engagement.
  • $450M raised through senior notes optimizes capital structure for future growth.

What critics are saying

  • CEO transition may lead to strategic shifts or instability during the transition period.
  • Increased competition from Tandem Diabetes Care could impact Insulet's market share.
  • Integration of Omnipod 5 with Dexcom G7 may face technical challenges or user adoption issues.

What makes Insulet Corporation unique

  • Omnipod is tubeless and waterproof, unlike traditional insulin pumps with tubing.
  • Omnipod 5 integrates with CGMs, offering automated insulin delivery for personalized diabetes management.
  • Insulet's global presence and innovative product line set it apart in diabetes care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Diabetic Investor
Jun 25th, 2025
ADA 2025 - Winners and losers

It goes without saying that Insulet was not just the winner of ADA 2025 it won by a landslide.

TTF Valve
Jun 12th, 2025
Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility - Simply Wall St News

Insulet (NasdaqGS:PODD) launches Omnipod 5 iPhone App with Dexcom G7 compatibility - Simply Wall St news.

MediaPost
Jun 11th, 2025
Insulet Boosts Its Diabetes Device Via Comical Campaign - And A Comic Book

Insulet has launched a humorous paid social campaign for its wearable Omnipod 5 insulin delivery system - and teamed with Marvel for a stigma-busting comic book starring a teen heroine with diabetes.

RTTNews
Apr 28th, 2025
Insulet CEO Jim Hollingshead Resigns, Ashley McEvoy To Succeed; Raises Q1 Guidance

Insulet Corp. (PODD), a medical device company, on Monday announced that Chief Executive Officer Jim Hollingshead has resigned from the Board of Directors.

MD+DI
Apr 28th, 2025
Insulet Names Ex-J&J MedTech Chief Ashley McEvoy as CEO

Ashley McEvoy has been tapped to be president and CEO of Insulet.